Tolero Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Tolero Pharmaceuticals's estimated annual revenue is currently $804k per year.(i)
  • Tolero Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Tolero Pharmaceuticals has 4 Employees.(i)
  • Tolero Pharmaceuticals grew their employee count by 0% last year.

Tolero Pharmaceuticals's People

NameTitleEmail/Phone
1
VP, Clinical ResearchReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.2M465%N/AN/A
#2
$17.3M864%N/AN/A
#3
$20.5M102-1%N/AN/A
#4
$7.6M38-3%N/AN/A
#5
$14.9M7437%N/AN/A
#6
$10.7M53-9%N/AN/A
#7
$6.2M317%N/AN/A
#8
$6.8M3413%N/AN/A
#9
$5.4M27-36%N/AN/A
#10
$305.9M15228%N/AN/A
Add Company

What Is Tolero Pharmaceuticals?

Tolero Pharmaceuticals is a clinical stage biopharmaceutical company developing treatments to improve and extend the lives of patients with serious oncological and hematological diseases. Our diverse pipeline targets important biological drivers of blood disorders to treat leukemias and anemia as well as important targets of drug resistance and transcriptional control.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$804k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tolero Pharmaceuticals News

2022-04-19 - Chemotherapy Induced Anemia Market Size, Outlook And ...

... Dr. Reddy's Laboratories, Pfizer, Panacea Biotec, 3SBio, SBI Pharmaceuticals, Tolero Pharmaceuticals, Vifor Pharma, Therapure Biopharma.

2022-04-19 - Activin Receptor Type 1 Market COVID 19 Impacted In-Depth ...

Blueprint Medicines Corp, Daiichi Sankyo Company Ltd, La Jolla Pharmaceutical Company, Oncodesign SA, Tolero Pharmaceuticals Inc.

2022-04-13 - Evolving Role of Prostate-Specific Membrane Antigen ...

Consulting or Advisory Role: Astellas Pharma, Janssen-Cilag, Ferring, ... Tolero Pharmaceuticals (Inst), MSD Oncology (Inst), Roche (Inst),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.3M4N/AN/A
#2
$0.6M4-43%N/A
#3
$0.3M4-20%N/A
#4
$0.3M4-33%N/A
#5
$0.3M4-20%N/A